S-Space

Browse

Subject

Jump to a point in the index

Or type in a year

Sort by
In order
Results/Page
Authors/record

Showing results 1 to 40 of 40

Issue Date	Title / Author(s) / Citation	File
2000-12	Adjuvant doxorubicin and cyclophosphamide versus cyclophosphamide, methotrexate, and 5-fluorouracil chemotherapy in premenopausal women with axillary lymph node positive breast carcinoma: Results of a randomized controlled trial Bang, Soo‐Mee; Heo, Dae Seog; Lee, Ki Hyeong; Byun, Jae Ho; Chang, Heung Moon; Noh, Dong‐Yong; Choe, Kuk Jin; Bang, Yung‐Jue; Kim, Sung Rok; Kim, Noe Kyeong Cancer, Vol.89 No.12, pp.2521-2526	DOI
2002-11	A phase III randomized trial of 5-fluorouracil, doxorubicin, and mitomycin C versus 5-fluorouracil and mitomycin C versus 5-fluorouracil alone in curatively resected gastric cancer Chang, HM; Jung, KH; Kim, TY; Kim, WS; Yang, HK; Lee, KU; Choe, KJ; Heo, DS; Bang, YJ; Kim, NK Annals of Oncology, Vol.13 No.11, pp.1779-1785	DOI
2003-01	Induction chemotherapy followed by radiotherapy in the treatment of anal cancer Lee, Dae Ho; Kim, Inho; Song, Hun Ho; Jung, Joo Young; Kim, Dae Young; Lee, Keun Wook; Kim, Tae-You; Heo, Dae Seog; Bang, Yung-Jue; Ha, Sung Whan; Park, Jae-Gahb; Kim, Noe Kyeong Oncology Reports, Vol.10 No.1, pp.101-104	DOI
2004-05	Neoadjuvant chemotherapy followed by radiotherapy in epidermoid carcinoma of anus Chie, Eui Kyu; Wu, Hong Gyun; Heo, Dae Seog; Bang, Young-Jue; Kim, Noe Kyeong; Ha, Sung W. Tumori, Vol.90 No.3, pp.299-302	DOI
2005-07	Docetaxel+5-fluorouracil plus cisplatin 3-day combination chemotherapy as a first-line treatment in patient with unresectable gastric cancer Oh, Do-Youn; Kim, Tae-Yong; Kwon, Jung Hye; Lee, Jae-Jin; Joh, Yohan; Kim, Dong-Wan; Kim, Tae-You; Heo, Dae Seog; Bang, Yung-Jue; Kim, Noe Kyeong Japanese Journal of Clinical Oncology, Vol.35 No.7, pp.380-385	DOI
2005-08	A phase II study of epirubicin, cisplatin and capecitabine combination chemotherapy in patients with metastatic or advanced gastric cancer Cho, EK; Lee, WK; Im, SA; Lee, SN; Park, SH; Bang, SM; Park, DK; Park, YH; Shin, DB; Lee, JH Oncology, Vol.68 No.4-6, pp.333-340	DOI
2005-10	Reduced dose intensity FOLFOX-4 as first line palliative chemotherapy in elderly patients with advanced colorectal cancer Kim, Jee Hyun; Oh, Do Youn; Kim, Yu Jung; Han, Sae Won; Choi, In-Sil; Kim, Dong Wan; Im, Seock Ah; Kim, Tae You; Lee, Jong Seok; Heo, Dae Seog; Bang, Yung-Jue; Kim, Noe Kyeong Journal of Korean Medical Science, Vol.20 No.5, pp.806-810	DOI
2008-07	Pemetrexed and cisplatin in patients with advanced gastric cancer: a Korean cancer study group multicenter phase II study Kim, Yeul Hong; Chung, Hyun Cheol; Kang, Won Ki; Park, Sook Ryun; Kim, Chul Soo; Kim, Tae-Yue; Shin, Sang Won; Park, Byung-Joo; Cha, Soo Jin; Bang, Yung-Jue Cancer Chemotherapy and Pharmacology, Vol.62 No.2, pp.263-270	DOI
2008-10	Capecitabine plus oxaliplatin (XELOX) versus 5-fluorouracil/folinic acid plus oxaliplatin (FOLFOX-4) as second-line therapy in metastatic colorectal cancer: a randomized phase III noninferiority study Rothenberg, M. L.; Cox, J. V.; Butts, C.; Navarro, M.; Bang, Y. -J.; Goel, R.; Gollins, S.; Siu, L. L.; Laguerre, S.; Cunningham, D. Annals of Oncology, Vol.19 No.10, pp.1720-1726	DOI
2009	Chemotherapy-induced transient CEA and CA19-9 surges in patients with metastatic or recurrent gastric cancer Kim, Hye Jin; Lee, Keun-Wook; Kim, Yu Jung; Oh, Do-youn; Kim, Jee Hyun; Im, Seock-ah; Lee, Jong Seok Acta Oncologica, Vol.48 No.3, pp.385-390	DOI
2009-03	Biomarker analysis in stage III-IV (M0) gastric cancer patients who received curative surgery followed by adjuvant 5-fluorouracil and cisplatin chemotherapy: epidermal growth factor receptor (EGFR) associated with favourable survival Kim, J. -S.; Kim, M. -A.; Kim, T. M.; Lee, S. -H.; Kim, D. -W.; Im, S. -A.; Kim, T. -Y.; Kim, W. H.; Yang, H. -K.; Heo, D. S.; Bang, Y. -J.; Lee, K. -U.; Choe, K. -J.; Kim, N. K. British Journal of Cancer, Vol.100 No.5, pp.732-738	DOI
2009-08	Class III beta-tubulin, but not ERCC1, is a strong predictive and prognostic marker in locally advanced head and neck squamous cell carcinoma Koh, Y.; Kim, T. M.; Jeon, Y. K.; Kwon, T. -K.; Hah, J. H.; Lee, S. -H.; Kim, D. -W.; Wu, H. -G.; Rhee, C. -S.; Sung, M. -W.; Kim, C. W.; Kim, K. H.; Heo, D. S. Annals of Oncology, Vol.20 No.8, pp.1414-1419	DOI
2010-08	Trastuzumab in combination with chemotherapy versus chemotherapy alone for treatment of HER2-positive advanced gastric or gastro-oesophageal junction cancer (ToGA): a phase 3, open-label, randomised controlled trial Bang, Yung-Jue; Van Cutsem, Eric; Feyereislova, Andrea; Chung, Hyun C.; Shen, Lin; Sawaki, Akira; Lordick, Florian; Ohtsu, Atsushi; Omuro, Yasushi; Satoh, Taroh; Aprile, Giuseppe; Kulikov, Evgeny; Hill, Julie; Lehle, Michaela; Ruschoff, Josef; Kang, Yoon-Koo The Lancet, Vol.376 No.9742, pp.687-697	DOI
2010-08	Biological characteristics and treatment outcomes of metastatic or recurrent neuroendocrine tumors: tumor grade and metastatic site are important for treatment strategy Kim, Su-Jung; Kim, Jin Won; Han, Sae-Won; Oh, Do-Youn; Lee, Se-Hoon; Kim, Dong-Wan; Im, Seock-Ah; Kim, Tae-You; Heo, Dae Seog; Bang, Yung-Jue BMC Cancer, Vol.10, p. 448	view file DOI
2010-09	A phase I/II and pharmacogenomic study of pemetrexed and cisplatin in patients with unresectable, advanced gastric carcinoma Chen, Jen-Shi; Chao, Yee; Bang, Yung-Jue; Roca, Enrique; Chung, Hyun C.; Palazzo, Felipe; Kim, Yeul H.; Myrand, Scott P.; Mullaney, Brian P.; Shen, Li J.; Linn, Carlos Anti-Cancer Drugs, Vol.21 No.8, pp.777-784	DOI
2011-02	Sunitinib Malate for the Treatment of Pancreatic Neuroendocrine Tumors. Raymond, Eric; Dahan, Laetitia; Raoul, Jean-Luc; Bang, Yung-Jue; Borbath, Ivan; Lombard-Bohas, Catherine; Valle, Juan; Metrakos, Peter; Smith, Denis; Vinik, Aaron; Chen, Jen-Shi; Hoersch, Dieter; Hammel, Pascal; Wiedenmann, Bertram; Van Cutsem, Eric; Patyna, Shem; Lu, Dongrui Ray; Blanckmeister, Carolyn; Chao, Richard; Ruszniewski, Philippe New England Journal of Medicine, Vol.364 No.6, pp.501-513	DOI
2011-06	Phase II study of biweekly S-1 and oxaliplatin combination chemotherapy in metastatic colorectal cancer and pharmacogenetic analysis Hong, Junshik; Han, Sae-Won; Ham, Hye Seon; Kim, Tae-Yong; Choi, In Sil; Kim, Byung-Su; Oh, Do-Youn; Im, Seock-Ah; Kang, Gyeong Hoon; Bang, Yung-Jue; Kim, Tae-You Cancer Chemotherapy and Pharmacology, Vol.67 No.6, pp.1323-1331	DOI
2011-10	Efficacy of infusional 5-fluorouracil, doxorubicin, and mitomycin-C (iFAM) in the treatment of patients with gemcitabine-pretreated pancreatic cancer and analysis of prognostic factors in a salvage setting Lim, Kyu-Hyoung; Kim, Tae-Yong; Lee, Kyung-Hun; Han, Sae-Won; Oh, Do-Youn; Im, Seock-Ah; Kim, Tae-You; Bang, Yung-Jue Cancer Chemotherapy and Pharmacology, Vol.68 No.4, pp.1017-1026	DOI
2011-11	Preoperative chemoradiation with cetuximab, irinotecan, and capecitabine in patients with locally advanced resectable rectal cancer: A multicenter phase II study Kim, Sun Young; Hong, Yong Sang; Kim, Dae Yong; Kim, Tae Won; Kim, Jee Hyun; Im, Seok Ah; Lee, Keun Seok; Yun, Tak; Jeong, Seung-Yong; Choi, Hyo Seong; Lim, Seok-Byung; Chang, Hee Jin; Jung, Kyung Hae International Journal of Radiation Oncology Biology Physics, Vol.81 No.3, pp.677-683	DOI
2012-12	Bevacizumab plus oxaliplatin-based chemotherapy as adjuvant treatment for colon cancer (AVANT): a phase 3 randomised controlled trial de Gramont, Aimery; Van Cutsem, Eric; Schmoll, Hans-Joachim; Tabernero, Josep; Clarke, Stephen; Moore, Malcolm J.; Cunningham, David; Cartwright, Thomas H.; Hecht, J. Randolph; Rivera, Fernando; Im, Seock-Ah; Bodoky, Gyoergy; Salazar, Ramon; Maindrault-Goebel, Frederique; Shacham-Shmueli, Einat; Bajetta, Emilio; Makrutzki, Martina; Shang, Aijing; Andre, Thierry; Hoff, Paulo M. The Lancet Oncology, Vol.13 No.12, pp.1225-1233	DOI
2013-04	The beneficial effect of palliative resection in metastatic colorectal cancer Park, J. H.; Kim, T-Y; Lee, K-H; Han, S-W; Oh, D-Y; Im, S-A; Kang, G. H.; Chie, E. K.; Ha, S. W.; Jeong, S-Y; Park, K. J.; Park, J-G; Kim, TY British Journal of Cancer, Vol.108 No.7, pp.1425-1431	DOI
2013-04	Pharmacogenetic analysis of adjuvant FOLFOX for Korean patients with colon cancer Lee, Kyung-Hun; Chang, Hye Jung; Han, Sae-Won; Oh, Do-Youn; Im, Seock-Ah; Bang, Yung-Jue; Kim, Sun Young; Lee, Keun-Wook; Kim, Jee Hyun; Hong, Yong Sang; Kim, Tae Won; Park, Young Suk; Kang, Won Ki; Shin, Sang Joon; Ahn, Joong Bae; Kang, Gyeong Hoon; Jeong, Seung-Yong; Park, Kyu Joo; Park, Jae-Gahb; Kim, Tae-You Cancer Chemotherapy and Pharmacology, Vol.71 No.4, pp.843-851	DOI
2013-04	Outcomes of surgery aiming at curative resection in good responder to induction chemotherapy for gastric cancer with distant metastases Han, Dong-Seok; Suh, Yun-Suhk; Kong, Seong-Ho; Lee, Hyuk-Joon; Im, Seock-Ah; Bang, Yung-Jue; Kim, Woo-Ho; Yang, Han-Kwang Journal of Surgical Oncology, Vol.107 No.5, pp.511-516	DOI
2013-05	Prognostic implication of mucinous histology in colorectal cancer patients treated with adjuvant FOLFOX chemotherapy Lee, D-W; Han, S-W; Lee, H. J.; Rhee, Y-Y; Bae, J. M.; Cho, N-Y; Lee, K-H; Kim, T-Y; Oh, D-Y; Im, S-A; Bang, Y-J; Jeong, S-Y; Park, K. J.; Park, J-G; Kang, G. H.; Kim, T-Y British Journal of Cancer, Vol.108 No.10, pp.1978-1984	DOI
2013-05	Methylation and microsatellite status and recurrence following adjuvant FOLFOX in colorectal cancer Han, Sae-Won; Lee, Hyun-Jung; Bae, Jeong Mo; Cho, Nam-Yun; Lee, Kyung-Hun; Kim, Tae-Yong; Oh, Do-Youn; Im, Seock-Ah; Bang, Yung-Jue; Jeong, Seung-Yong; Park, Kyu Joo; Park, Jae-Gahb; Kang, Gyeong Hoon; Kim, Tae-You International Journal of Cancer, Vol.132 No.9, pp.2209-2216	DOI
2013-07	Clinical outcomes of radiation-based locoregional therapy in locally advanced head and neck squamous cell carcinoma patients not responding to induction chemotherapy Lim, Yoojoo; Keam, Bhumsuk; Koh, Youngil; Kim, Tae Min; Lee, Se-Hoon; Hah, J. Hun; Kwon, Tack-Kyun; Kim, Dong-Wan; Wu, Hong-Gyun; Sung, Myung-Whun; Heo, Dae Seog; Kim, Kwang Hyun Oral Surgery Oral Medicine Oral Pathology Oral Radiology, Vol.116 No.1, pp.55-60	DOI
2014-02	A Phase II Study of Bevacizumab, Oxaliplatin, and Capecitabine in Patients With Previously Untreated Metastatic Colorectal Cancer A Prospective, Multicenter Trial of the Korean Cancer Study Group Hong, Yong Sang; Lee, Sung Sook; Kim, Kyu-pyo; Lee, Jae-Lyun; Kang, Yoon-Koo; Shin, Sang Joon; Ahn, Joong Bae; Jung, Kyung Hae; Im, Seock-Ah; Kim, Tae-You; Kim, Jee Hyun; Park, Young Suk; Kim, Tae Won American Journal of Clinical Oncology, Vol.37 No.1, pp.19-23	DOI
2014-07	Quality of Life in the Trastuzumab for Gastric Cancer Trial Satoh, Taroh; Bang, Yung-Jue; Gotovkin, Evgeny A.; Hamamoto, Yasuo; Kang, Yoon-Koo; Moiseyenko, Vladimir M.; Ohtsu, Atsushi; Van Cutsem, Eric; Al-Sakaff, Nedal; Urspruch, Alexa; Hill, Julie; Weber, Harald A.; Chung, Hyun-Cheol Oncologist, Vol.19 No.7, pp.712-719	DOI
2015-10	Prognostic influence of body mass index and body weight gain during adjuvant FOLFOX chemotherapy in Korean colorectal cancer patients Lee, Dae-Won; Han, Sae-Won; Cha, Yongjun; Lee, Kyung-Hun; Kim, Tae-Yong; Oh, Do-Youn; Im, Seock-Ah; Bang, Yung-Jue; Park, Ji Won; Ryoo, Seung-Bum; Jeong, Seung-Yong; Kang, Gyeong Hoon; Park, Kyu Joo; Kim, Tae-You BMC Cancer, Vol.15, p. 690	view file DOI
2015-10	A Randomized, Multicenter, Phase II Study of Cetuximab With Docetaxel and Cisplatin as Induction Chemotherapy in Unresectable, Locally Advanced Head and Neck Cancer Lee, Keun-Wook; Koh, Youngil; Kim, Sung-Bae; Shin, Sang-Won; Kang, Jin-Hyoung; Wu, Hong-Gyun; Sung, Myung-Whun; Keam, Bhumsuk; Kim, Dong-Wan; Kim, Tae Min; Kim, Kwang Hyun; Kwon, Tack-Kyun; Hah, J. Hun; Kim, In-Ah; Ahn, Soon-Hyun; Yoon, Dok Hyun; Lee, Sang-Wook; Kim, Sang Yoon; Nam, Soon Yuhl; Jung, Kwang-Yoon; Baek, Seung-Kuk; Hong, Sook Hee; Lee, Se-Hoon; Heo, Dae Seog Oncologist, Vol.20 No.10, pp.1119-1120	DOI
2016-02	Effect of induction chemotherapy on survival in locally advanced head and neck squamous cell carcinoma treated with concurrent chemoradiotherapy: Single center experience Ock, Chan-Young; Keam, Bhumsuk; Lim, Yoojoo; Kim, Tae Min; Lee, Se-Hoon; Kwon, Seong Keun; Hah, J. Hun; Kwon, Tack-Kyun; Kim, Dong-Wan; Wu, Hong-Gyun; Sung, Myung-Whun; Heo, Dae Seog Head and Neck, Vol.38 No.2, pp.277-284	DOI
2016-05	Induction chemotherapy in head and neck squamous cell carcinoma of the paranasal sinus and nasal cavity: A role in organ preservation Ock, Chan-Young; Keam, Bhumsuk; Kim, Tae Min; Han, Doo Hee; Won, Tae-Bin; Lee, Se-Hoon; Hah, J. Hun; Kwon, Tack-Kyun; Kim, Dong-Wan; Kim, Dong-Young; Rhee, Chae-Seo; Wu, Hong-Gyun; Sung, Myung-Whun; Heo, Dae Seog The Korean Journal of Internal Medicine, Vol.31 No.3, pp.570-578	view file DOI
2016-07	Splenomegaly and Its Associations with Genetic Polymorphisms and Treatment Outcome in Colorectal Cancer Patients Treated with Adjuvant FOLFOX Kim, Mi-Jung; Han, Sae-Won; Lee, Dae-Won; Cha, Yongjun; Lee, Kyung-Hun; Kim, Tae-Yong; Oh, Do-Youn; Kim, Se Hyung; Im, Seock-Ah; Bang, Yung-Jue; Kim, Tae-You Cancer Research and Treatment, Vol.48 No.3, pp.990-997	DOI
2018-03	A phase II trial of S-1 and oxaliplatin in patients with advanced hepatocellular carcinoma Lee, Dae-Won; Lee, Kyung-Hun; Kim, Hee-Jun; Kim, Tae-Yong; Kim, Jin-Soo; Han, Sae-Won; Oh, Do-Youn; Kim, Jee Hyun; Im, Seock-Ah; Kim, Tae-You BMC Cancer, Vol.18 No.1, p. 252	DOI
2019-07	Pembrolizumab alone or in combination with chemotherapy as first-line therapy for patients with advanced gastric or gastroesophageal junction adenocarcinoma: results from the phase II nonrandomized KEYNOTE-059 study Bang, Yung-Jue; Kang, Yoon-Koo; Catenacci, Daniel V.; Muro, Kei; Fuchs, Charles S.; Geva, Ravit; Hara, Hiroki; Golan, Talia; Garrido, Marcelo; Jalal, Shadia I.; Borg, Christophe; Doi, Toshihiko; Yoon, Harry H.; Savage, Mary J.; Wang, Jiangdian; Dalal, Rita P.; Shah, Sukrut; Wainberg, Zev A.; Chung, Hyun Cheol Gastric Cancer, Vol.22 No.4, pp.828-837	DOI
2020-02	Bevacizumab as adjuvant treatment of colon cancer: updated results from the S-AVANT phase III study by the GERCOR Group Andre, T.; Vernerey, D.; Im, S. A.; Bodoky, G.; Buzzoni, R.; Reingold, S.; Rivera, F.; McKendrick, J.; Scheithauer, W.; Ravit, G.; Fountzilas, G.; Yong, W. P.; Isaacs, R.; Osterlund, P.; Liang, J. T.; Creemers, G. J.; Rakez, M.; Van Cutsem, E.; Cunningham, D.; Tabernero, J.; de Gramont, A. Annals of Oncology, Vol.31 No.2, pp.246-256	DOI
2020-08	S-1 plus leucovorin and oxaliplatin versus S-1 plus cisplatin as first-line therapy in patients with advanced gastric cancer (SOLAR): a randomised, open-label, phase 3 trial Kang, Yoon-Koo; Chin, Keisho; Chung, Hyun Cheol; Kadowaki, Shigenori; Oh, Sang Cheul; Nakayama, Norisuke; Lee, Keun-Wook; Hara, Hiroki; Chung, Ik-Joo; Tsuda, Masahiro; Park, Se Hoon; Hosaka, Hisashi; Hironaka, Shuichi; Miyata, Yoshinori; Ryu, Min-Hee; Baba, Hideo; Hyodo, Ichinosuke; Bang, Yung-Jue; Boku, Narikazu The Lancet Oncology, Vol.21 No.8, pp.1045-1056	DOI
2020-10	Efficacy and Safety of Pembrolizumab or Pembrolizumab Plus Chemotherapy vs Chemotherapy Alone for Patients With First-line, Advanced Gastric Cancer: The KEYNOTE-062 Phase 3 Randomized Clinical Trial Shitara, Kohei; Van Cutsem, Eric; Bang, Yung-Jue; Fuchs, Charles; Wyrwicz, Lucjan; Lee, Keun-Wook; Kudaba, Iveta; Garrido, Marcelo; Chung, Hyun Cheol; Lee, Jeeyun; Castro, Hugo Raul; Mansoor, Wasat; Braghiroli, Maria Ignez; Karaseva, Nina; Caglevic, Christian; Villanueva, Luis; Goekkurt, Eray; Satake, Hironaga; Enzinger, Peter; Alsina, Maria; Benson, Al; Chao, Joseph; Ko, Andrew H.; Wainberg, Zev A.; Kher, Uma; Shah, Sukrut; Kang, S. Peter; Tabernero, Josep JAMA oncology, Vol.6 No.10, pp.1571-1580	DOI
2023-04	A Phase II Trial of S-1 and Oxaliplatin in Patients with Metastatic Breast Cancer Previously Treated with Anthracycline and Taxane (KCSG-BR07-03) Lee, Dae-Won; Keam, Bhumsuk; Lee, Keun Seok; Ahn, Jin-Hee; Sohn, Joohyuk; Ahn, Jin Seok; Lee, Moon Hee; Kim, Jee Hyun; Lee, Kyung Eun; Kim, Hyo Jung; Kim, Si-Young; Park, Yeon Hee; Ock, Chan-Young; Lee, Kyung-Hun; Han, Sae-Won; Kim, Sung-Bae; Im, Young Hyuck; Chung, Hyun Cheol; Oh, Do-Youn; Im, Seock-Ah Cancer Research and Treatment, Vol.55 No.2, pp.523-530	DOI
2023-06	Efficacy and safety of maintenance therapy with pamiparib versus placebo for advanced gastric cancer responding to first-line platinum-based chemotherapy: Phase 2 study results Ciardiello, Fortunato; Bang, Yung-Jue; Cervantes, Andres; Dvorkin, Mikhail; Lopez, Charles D.; Metges, Jean-Philippe; Sanchez Ruiz, Antonio; Calvo, Mariona; Strickland, Andrew H.; Kannourakis, George; Muro, Kei; Kawakami, Hisato; Wei, Jia; Borg, Christophe; Zhu, Zhaoyin; Gupta, Neal; Pelham, Robert J.; Shen, Lin Cancer Medicine, Vol.12 No.12, pp.1-10	DOI